a
a
New Pill Making Waves in Sleep Apnea
Could there be a new approach — a simple pill — that eases sleep apnea symptoms and replaces more conventional treatments?
That's what researchers at Apnimed hope. Apnimed is a company that's developed a new oral drug for sleep apnea — currently called AD109. AD109 combines the drugs aroxybutynin and atomoxetine.
Aroxybutynin is used to treat symptoms of an overactive bladder, while atomoxetine is used to treat attention deficit hyperactivity disorder.
a
a
No comments:
Post a Comment